0001209191-15-062601.txt : 20150727 0001209191-15-062601.hdr.sgml : 20150727 20150727193506 ACCESSION NUMBER: 0001209191-15-062601 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150727 FILED AS OF DATE: 20150727 DATE AS OF CHANGE: 20150727 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NantKwest, Inc. CENTRAL INDEX KEY: 0001326110 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 431979754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2533 SOUTH COAST HIGHWAY 101 STREET 2: SUITE 210 CITY: CARDIFF-BY-THE-SEA STATE: CA ZIP: 92007 BUSINESS PHONE: (858) 633-0300 MAIL ADDRESS: STREET 1: 2533 SOUTH COAST HIGHWAY 101 STREET 2: SUITE 210 CITY: CARDIFF-BY-THE-SEA STATE: CA ZIP: 92007 FORMER COMPANY: FORMER CONFORMED NAME: Conkwest, Inc. DATE OF NAME CHANGE: 20140416 FORMER COMPANY: FORMER CONFORMED NAME: ZelleRx Corp DATE OF NAME CHANGE: 20050504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas John C CENTRAL INDEX KEY: 0001424620 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37507 FILM NUMBER: 151008030 MAIL ADDRESS: STREET 1: 8601 SIX FORKS ROAD, SUITE 160 CITY: RALEIGH STATE: NC ZIP: 27615 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2015-07-27 0 0001326110 NantKwest, Inc. NK 0001424620 Thomas John C C/O NANTKWEST, INC. 2533 SOUTH COAST HIGHWAY 101, SUITE 210 CARDIFF-BY-THE-SEA CA 92007-2133 1 0 0 0 Common Stock 92575 D Stock Option (right to buy) 0.2161 2024-03-17 Common Stock 277725 D Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is March 17, 2014. The option originally covered 200,000 pre 1.8515 for 1 forward split shares. /s/ Richard Gomberg, as Attorney-in-Fact 2015-07-27 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY

      The undersigned, as a Section 16 reporting person of NantKwest, Inc. (the
"Company"), hereby constitutes and appoints Barry J. Simon, Richard Gomberg,
Charles Kim, Daniel R. Koeppen, Daniel Horwood, and Martin J. Waters the
undersigned's true and lawful attorneys-in-fact to:

1.	complete and execute Forms 3, 4 and 5 and other forms and all amendments
thereto as such attorneys-in-fact shall in their discretion determine to be
required or advisable pursuant to Section 16 of the Securities Exchange Act of
1934 (as amended) and the rules and regulations promulgated thereunder, or any
successor laws and regulations, as a consequence of the undersigned's ownership,
acquisition or disposition of securities of the Company; and

2.	do all acts necessary in order to file such forms with the Securities and
Exchange Commission, any securities exchange or national association, the
Company and such other person or agency as the attorneys-in-fact shall deem
appropriate.

      The undersigned hereby ratifies and confirms all that said
attorneys-in-fact and agent shall do or cause to be done by virtue hereof.  The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934 (as amended).

      This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 27th day of July, 2015.


Signature: /s/ John C. Thomas, Jr.

Print Name:  John C. Thomas, Jr.




Exhibit 24